Arbutus Biopharma Corporation (ABUS)
NASDAQ:ABUS
Holding ABUS?
Track your performance easily

Arbutus Biopharma (ABUS) Financial Statements

1,204 Followers

Arbutus Biopharma Financial Overview

Arbutus Biopharma's market cap is currently ―. The company's EPS TTM is $-0.441; its P/E ratio is -9.24; Arbutus Biopharma is scheduled to report earnings on November 6, 2024, and the estimated EPS forecast is $-0.09. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Dec 23Sep 23Jun 23
Income Statement-
Total Revenue$ 1.73M$ 1.53M$ 2.15M$ 4.66M$ 3.88M
Gross Profit$ 1.73M$ 1.53M$ 2.15M$ 4.66M$ 4.65M
EBIT$ -19.76M$ -17.83M$ -19.27M$ -20.06M$ -16.92M
EBITDA$ -18.85M$ -17.48M$ -18.91M$ -20.35M$ -17.11M
Net Income Common Stockholders$ -19.52M$ -17.88M$ -19.31M$ -19.11M$ -17.09M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 141.99M$ 129.24M$ 126.00M$ 134.18M$ 152.48M
Total Assets$ 160.04M$ 150.29M$ 144.40M$ 158.64M$ 176.82M
Total Debt$ 1.60M$ 1.68M$ 1.77M$ 1.91M$ 2.04M
Net Debt$ -140.39M$ -127.56M$ -124.23M$ -132.27M$ -150.44M
Total Liabilities$ 37.59M$ 35.65M$ 38.38M$ 39.30M$ 42.13M
Stockholders Equity$ 122.45M$ 114.64M$ 106.02M$ 119.34M$ 134.69M
Cash Flow-
Free Cash Flow$ -14.51M$ -19.39M$ -17.29M$ -22.16M$ -19.78M
Operating Cash Flow$ -14.50M$ -19.30M$ -17.29M$ -22.15M$ -18.92M
Investing Cash Flow$ 9.83M$ 11.69M$ 22.23M$ 10.79M$ 805.00K
Financing Cash Flow$ 24.37M$ 24.43M$ 3.81M$ 1.68M$ 4.74M
Currency in USD

Arbutus Biopharma Earnings and Revenue History

Arbutus Biopharma Debt to Assets

Arbutus Biopharma Cash Flow

Arbutus Biopharma Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis